Tezepelumab in Patients With Severe Asthma: Response at 3 Months
J Investig Allergol Clin Immunol
.
2024 Nov 25:0.
doi: 10.18176/jiaci.1041.
Online ahead of print.
Authors
J C Miralles-López
1
,
R Andújar-Espinosa
2
,
F J Bravo-Gutierrez
3
,
S Cabrejos-Perotti
4
,
M Ramírez-Hernández
4
,
C Díaz-Chantar
5
,
M J Pajarón-Fernández
6
,
J Valverde-Molina
7
,
V Pérez-Fernández
8
;
RE-ASGRAMUR GROUP
Affiliations
1
Allergy Department, University General Hospital Reina Sofía, Murcia, Spain.
2
Pulmonology Department, University Clinic Hospital Virgen de la Arrixaca, Murcia, Spain.
3
Pulmonology Department, University General Hospital Santa Lucia, Cartagena, Murcia, Spain.
4
Allergy Department, University General Hospital Santa Lucia, Cartagena, Murcia, Spain.
5
Pulmonology Department, Hospital de la Vega Lorenzo Guirao, Cieza, Spain.
6
Allergy Department, Hospital de la Vega Lorenzo Guirao, Cieza, Spain.
7
Pediatrics Department, University General Hospital Santa Lucia, Cartagena, Murcia, Spain.
8
Department of Public Health Sciences, University of Murcia School of Medicine, Murcia, Spain.
PMID:
39584417
DOI:
10.18176/jiaci.1041
No abstract available
Keywords:
Real-life; Response to treatment; Severe asthma; Tezepelumab.